Drug panel favours nod for Covovax as Covid booster

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/G6rVI0s

Comments

Popular posts from this blog

G20 live: PM holds talks with Brazilian Prez

Can’t make Covid orphans run around: Delhi HC